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quently exposed to drugs, which, “per se” repre-
sents a risk factor for DA8 and thus normal control
would be inappropriate. Pope et al5 studied DA in
SLE patients using self-report data from age and sex
matched controls with inflammatory arthritis. It
was found that, with the exception of skin rash for
sulfonamides other DA were not more frequent in
SLE. The other possibilities for the reported diffe-
rences would be differences in the ethnicity of con-
trol groups and the means of ascertaining allergic
manifestations,5 with medical record review1 repor-
ting lower frequencies than self-reported.5 Finally,
making the attribution of any allergic manifestation
must deal with the fact that drug2,3 may exacerba-
te or even induce SLE.9 For instance, sulfonamides
may cause flares in SLE patients.9 In addition some
manifestations, such as fever, rash and oral ulcers,
might be attributed to DA but in fact may be a fea-
ture of SLE exacerbation.
Case report
A 30-year-old Portuguese female law student pre-
sented to our emergency room with a 3-day history
of a progressive maculopapular rash that started
over her legs, odynophagia, minimally productive
cough and non-bloody diarrhoea 5-6 times a day.
Three days before her admission, she had consul-
ted her dentist for dental pain and was given the
combination of amoxicillin 875 mg and clavulanic
acid 125 mg bid. She had a history of a rash to pe-
nicillin. After taking the second tablet, she develo-
ped chills, malaise, myalgia and a rash over lower
extremities.
The patient had a 12-year history of SLE mani-
fested by malar rash, photosensitivity, oral ulcers
and alopecia, leukopenia, polyarthritis and WHO
class IV diffuse membranoproliferative nephritis.
When she was seen 2 months before, her SLE disea-
se activity measured by SLAM-R was 3 (Table I) with
stable doses of prednisone 20 mg qd and azathio-
prine 50 mg bid. She was also on captopril 50 mg
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Abstract
We report a case of severe type IV hypersensitivity
reaction to amoxicillin, which occurred in a person
with a 12-year history of SLE. The present case il-
lustrates the wide differential diagnosis in a SLE
patient who presents with an allergic drug reac-
tion. The attribution of the presenting symptoms to
the underlying SLE and/or to the drugs used to tre-
at SLE and coexisting conditions is a major chal-
lenge. 
Keywords: Systemic Lupus Erythematosus; Drug
Hypersensitivity; Amoxicillin; Simvastatin; Rhab-
domyolysis.
Introduction
Allergic drug reactions may be increased in Syste-
mic Lupus Erythematosus (SLE) patients. Some
studies show that drug allergies (DA) are similar in
SLE and controls,1,2 others suggest that SLE patients
have an increased risk of DA.3-7 One explanation for
discrepancies between these studies is the choice
of controls and whether they are normal indivi-
duals or disease controls. SLE patients are more fre-
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bid, simvastatin 20 mg qd, furosemide 20 mg qd
and folic acid 5 mg qd. 
In the emergency room, her physical examina-
tion showed an alert but ill woman, bilateral con-
junctival haemorrhages, generalized purpuric rash,
and a temperature of 39.5º C. Her pulse was
111/min, her blood pressure was 103/70 mm Hg;
the rest of her physical examination was normal.
Laboratory tests showed high values of serum
creatinine (4.6 mg/L) and C-reactive protein 
(29.8 mg/dL), hypoalbuminemia (2.9 g/dL), eleva-
ted SGOT (311 U/L), SGPT (86 U/L) and CPK 
(24220 U/L). Her lymphocytes (1.1x103/µl) and pla-
telets (57x103/µL) were low (Table II). There was no
eosinophilia. Her urine dipstick showed 3+ protei-
nuria and hematuria. Her arterial blood gases
showed pH=7.39 [7.35-7.45]; paO2=118 mm Hg 
[85-108]; pCO2=21.2 mm Hg [35-45] and HCO3= 
12.7 mmol/L [21-29]. The chest X-ray showed dif-
fuse bilateral lung interstitial infiltrates. 
The presumptive diagnoses at emergency room
were sepsis, drug allergic reaction to the antibio-
tic, rhabdomyolysis with secondary acute renal fai-
lure and a SLE flare. She received intravenous 
fluids, paracetamol, bicarbonate, imipenem, a 250
mg iv bolus of methylprednisolone followed by oral
prednisone 60 mg qd, intramuscular clemastin and
supportive care.
After admission to the rheumatology ward,
prednisone was tapered from 60 mg qd to 20 mg
over 13 days and she was given hydroxyzine 25 mg
qd, furosemide 20 mg bid and albumin 1 g tid. Her
skin lesions were treated with topical 0.1% betame-
thasone. By the third day she became afebrile, wi-
thout constitutional symptoms, skin lesions beca-
me vesicular and epidermolysis occurred. Antibio-
therapy was stopped at the 8th hospital day. Labo-
ratory values normalized as she recovered (Figures
1 and 2). Sputum was unobtainable and a subse-
quent chest film showed clearing of the infiltrates
present at admission.
Blood, urine and stool cultures, serology for EBV,
CMV, parvovirus B19 and coxsackie were negative.
Anti-dsDNA antibody was 34.2 U/ml [<4.2 U/ml],
C3 0.78 g/L [0.9-1.8] and C4 0.2 g/L [0.1-0.4]. She
had a proteinuria of 2.88 g/day, which persisted
after creatinine and CPK normalization. Except for
proteinuria, urinalysis did not show abnormaliti-
es (Table I); myoglobin, red cell casts and dysmor-
phic red blood cells were absent. Her disease acti-
vity measured by SLAM-R was 9. A repeat renal
biopsy showed WHO class IV-C diffuse proliphera-
tive glomerulonephritis, with diffuse and segmen-
Table I. Comparison of laboratorial values at baseline and on admission 
Baseline values Admission values Reference values
Hgb 11.9 13.0 11.5–16.5 g/dl
WBC 3.5 8.4 4–11 x103/µL
Blood Lymphocytes 0.7 1.1 1.5-4.95 x103/µL
Platelets 118 57 150–400x103/µL
C3 / C4 not available 0.78 / 0.2 0.9–1.8 / 0.1–0.4 g/L
Anti-dsDNA not available 34.2 <4.2 U/ml
Urine Protein 10 193 0–20 mg/dl
Leucocytes 7.4 29.4 1.0–36.0/µL
Red blood cells 2.0 28.3 1.0–43.0/µL
SLAM-R 3 9 0–81
Hgb- haemoglobin;WBC- White blood cells; SLAM-R: SLE Activity Measure-Revised
Table II. Laboratorial values on admission
Reference 
Value values
Creatinine 4.6 0.6-1 mg/dl
CRP 29.8 0-0.82 mg/l
Albumine 2.9 3.5-5 g/dl
SGOT 311 5-34 U/L
SGPT 86 5-34 U/L
CK 24220 29-168 U/L




ÓRGÃO OF IC IAL DA SOC IEDADE PORTUGUESA DE REUMATOLOGIA - ACTA REUMATOL PORT. 2009;34:526-530
528
SLE AND ALLERGIC DRUG REACTION
tal sclerosis without active lesions (Figures 3 and
4). Intradermal skin tests confirmed type IV hyper-
sensitivity to amoxicillin, ampicilin and dicloxa-
cillin.
The patient was discharged at the 28th hospital
day treated with prednisolone 10 mg qid, furosemi-
de 40 mg bid, enalapril 5 mg qid and azathioprine
50 mg bid. After discharge, the Nephrologist decided
to change azathioprine for mycophenolate mofetil
1 g bid, stopped after one year due to lack of bene-
fit. She continues her follow-up at the Rheumato-
logy and Nephrology Outpatient Clinics. She main-
tains mild chronic renal insufficiency with a SLAM-
R score of 3 (low disease activity) at last visit.
Discussion
In this patient several diagnoses had to be consi-
dered. These were in order of likelihood: 1) amoxi-
cillin hypersensitivity; 2) sepsis; 3) rhabdomyolysis
from simvastatin precipitated by amoxicillin he-
patotoxicity; 4) sepsis causing a lupus flare; 5) amo-
xicillin- induced lupus flare or 6) some combina-
tion of the above.
Drug allergy (DA) to amoxicillin was the most
probable precipitating event considering the pati-
ent’s previous history, the temporal sequence of
events and because allergic reactions to β-lactamic
drugs are common. Our patient presented a type
IV hypersensitivity reaction, which can occur from
one hour to several days after re-exposure to the
drug, more commonly 48-72 hours after.10 This re-
action differs from an immediate hypersensitivity
reaction, which generally appears within 12 minu-
tes and no longer than one hour of an antigen chal-
lenge with urticaria with or without angioedema or
anaphilaxis.1 There is evidence that the longer the
interval between drug intake and appearance of
the reaction the less the probability of being IgE
mediated. The patient had no family or personal
history of atopy, which has been associated with an
increased risk of DA.2 The onset of maculopapular
lesions occurring after the re-exposure to antibio-
tics is typical of Type IV hypersensitivity reactions.3
As the mechanism is not IgE-mediated, measuring
IgE specific to amoxicillin would not help confirm
the diagnosis. The use of skin testing, such as in-
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Figure 2. Evolution of creatinine and CPK over time
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tradermal or patch testing is somewhat controver-
sial and some contend that is particularly not help-
ful in autoimmune diseases like SLE.3
Oral challenge test with amoxicillin is the diag-
nostic gold standard test,4 but in this patient it was
contraindicated because she had a severe event
and testing was potentially dangerous or even fa-
tal. In this case, the positive intradermal test to
amoxicillin helped to confirm the diagnosis. 
The other major differential was sepsis from her
dental infection. High fever, hypotension and ele-
vated CRP made sepsis diagnosis very likely and
thus the decision to treat her immediately with an-
tibiotic. Knowledge of a previous allergy to Benzyl
penicillin could have prevented this hospitalizati-
on; penicillin, amoxicillin and, to a lesser extent
cephalosporins share extensive cross-reactivity.5
One might also question the use of imipenem du-
ring her hospitalization as it is a β-lactamic and its
cross-reactivity is not fully known.6,7 Rhabdo-
myolysis is uncommon in amoxicillin DA, but is a
known and rare adverse effect of simvastatin and
thought to be dose-related. Hepatotoxicity has
been described in amoxicillin and liver injury could
interfere with the metabolism of simvastatin re-
sulting in higher drug levels leading to muscle ne-
crosis. Acute renal failure develops in 30-40% of
patients with rhabdomyolysis. Suggested mecha-
nisms include precipitation of myoglobin and uric
acid crystals within renal tubules, decreased glo-
merular perfusion, and the nephrotoxic effect of
ferrihemate (formed upon dissociation of myoglo-
bin in the acidic environment of the renal pa-
renchyma).8
Infection2,7 and drugs,9 including antibiotics can
trigger a systemic lupus flare or the patient could
have had a lupus flare not related to these. The pre-
sence of chills, neutrophilia, leucocytosis are
thought to be markers of infection rather than
SLE11 and our patient had these features. The pati-
ent had SLE class IV diffuse glomerulonephritis
since ten years before. On this admission, presen-
ce of fever, hypocomplementemia, lymphopenia,
thrombocytopenia, elevated anti-dsDNA and al-
most nephrotic-range proteinuria (compared to
her baseline) favours a lupus flare. A non-renal lu-
pus flare is likely to have occurred. The reversal of
acute renal failure could relate to improvement of
the drug reaction but a lupus nephritis flare could
also have improved with the increase in steroid
therapy. However, the argument for a lupus nephri-
tis flare is weak, since the renal biopsy showed no
evidence of active lesions. Furthermore, the trial
with mycophenolate mofetil produced no impro-
vement, as expected from the biopsy.   
In conclusion, the most likely causal pathway for
the most severe manifestations was a type IV hyper-
sensitivity reaction due to amoxicillin causing he-
patotoxicity leading to increased simvastatin pre-
cipitating rhabdomyolysis and acute renal failure.
Also, a non-renal lupus flare and possibly an infec-
tion likely occurred in this complex clinical case.
Correspondence to:
Maura Couto 




Figure 3. Two hyaline glomeruli with global sclerosis;
chronic interstitial nephritis with fibrosis (PAS staining;
magnification: 20x)
Figure 4. Two hyaline glomeruli and peritubular sclerosis
with epithelial atrophy (Masson tricromic staining;
magnification: 20x)
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